The role of interleukin 1 (IL-1) in tumour - NK cell interactions:- Correction of defective NK cell activity in cancer patients by treating target cells with IL-1
✍ Scribed by Arthur R. Rabson; Jean Herman; Michael C. Kew; Charles A. Dinarello
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 95 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The combination therapy of CPT‐11, a prodrug of SN‐38, with S‐1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, shows a high clinical response rate in non‐small cell lung cancer (NSCLC). However, this combination causes severe toxicities such as diarrhea. Here, we invest
## Abstract IL‐1β is an important mediator in the pathogenesis of type 1 diabetes both in vivo and in vitro and it has been shown to induce islet β‐cell apoptosis. Most of the IL‐1β effects seem to be mediated by NF‐κB transcription factor activation, but its role in the induction of islet β‐cell a
## Abstract In recent studies, sodium arsenite (SA) inhibited IL‐6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor‐kappaB (NF‐κB). The influence of SA on the activity of other transcription factors regulating the interleukin‐6 (_